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Abstract
While the important and varied roles that vascular cells play in both health and disease is 
well recognised, the focus on potential therapeutic targets continually shifts as new players 
emerge. Here, we outline how mitochondria may be viewed as more than simply energy-
generating organelles, but instead as important sentinels of metabolic health and effectors 
of appropriate responses to physiological challenges.
Angiogenesis
Angiogenesis, the growth of new blood vessels from an 
existing capillary bed (de novo creation of capillaries, 
neovascularisation, is a distinct process), is not only 
essential in the maintenance of tissue/organ health, but 
also intimately involved in the development of many 
diseases. This process is commonly viewed as proliferation 
and migration of endothelial cells (ECs) towards chemical 
signals (angiogenic growth factors) within the extracellular 
matrix, although variations on this canonical pathway 
have been described (1). ECs line all blood vessels and 
form their smallest entity (the capillaries) that act as the 
diffusive barrier to O2 and nutritive exchange at the blood/
tissue interface. The growth of new capillaries will extend 
microcirculatory transport and metabolic capacity, but 
by nature ECs are one of the most quiescent cell types in 
the body. As such ECs require a strong signal to stimulate 
release from contact-inhibition and low turnover rate in 
order to promote angiogenesis. An effective angiogenic 
signal, therefore, has to overcome a potent drive for 
stability in this tubular monolayer of cells. In healthy 
individuals angiogenesis forms an essential component 
of, for example, the female reproductive tract cycle, 
wound repair, and adaptive remodelling induced by 
exercise training (1). It is recognised that tight control 
over the angiogenic process is due to tonic influences of 
both pro- and anti-angiogenic factors, with an altered 
balance promoting either expansion or rarefaction of 
the capillary bed (1, 2). However, dysfunctional feedback 
control results in abnormal blood vessel growth, which 
may be excessive or insufficient depending on the relative 
strength of stimuli influencing angioadaptation in 
response to humoral factors and the local environment. 
Capillaries are much more than a mere physical conduit 
for erythrocytes delivering O2 to respiring tissues; they 
are crucial for the removal of waste products, contribute 
to acid/base and iono/osmo regulation, and impact 
immune reaction. By virtue of their huge surface area the 
endothelium is an important interface between systemic 
hormonal signalling and tissue metabolic responses. 
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a major contribution to the aetiology and maintenance 
of multiple disorders, including those associated with 
serious risk of mortality and/or level of morbidity, such 
as cancer, cardiovascular disease, diabetes, stroke, age-
related blindness, psoriasis, rheumatoid arthritis (3) (see 
also Table 1).
Role of mitochondria in the vasculature
An important role of EC in the microcirculation is to 
sense disturbances in physiological set-points in organ 
systems, such as reacting to changes in haemodynamic 
forces following altered tissue perfusion (e.g. act as a 
mechanotransducer for elevated shear stress during skeletal 
muscle functional hyperaemia) or to local paracrine 
growth factor production (e.g. act as a chemotransducer 
during endometrial hypertrophy or tumour progression). 
There is clearly great incentive to develop pro-angiogenic 
therapies and anti-angiogenic treatments, but many 
current approaches need refinement, with combination 
angiotherapies likely required to provide better efficacy 
and less toxicity (4). Alternative approaches are 
therefore required. Understanding the role of EC in the 
microcirculation, and in angiogenesis in particular, may 
help focus attention on profitable routes of enquiry 
including the role of endothelial cell metabolism (2). 
Hypoxia is thought to be a key driver for vascular 
remodelling, with observations of oxygen sensing at the 
capillary level (5) providing a plausible HIF1α-VEGF route 
linking supply and demand. Mitochondrial function is 
an important, but underutilised target for improving 
vascular function, including regulation of vascular tone 
by activation of mitochondrial KATP channels or ROS 
production within vascular smooth muscle (6). More 
recently, a key role has also been suggested for the 
mitochondria in EC (7). Given their location adjacent to 
the source of oxygen delivery, it may seem paradoxical that 
the mitochondrial content in EC is relatively modest: 2–6% 
of cytoplasm volume (cf. ~32% in cardiomyocytes (2)). 
Further, it appears that energy requirement of EC 
mitochondria is relatively low compared to myocytes and 
other cell types that they support (e.g. via transport of 
nutrients). Indeed, EC are generally fuelled by glycolytic 
(anaerobic) metabolism, where up to 80% of ATP is 
generated by oxygen-independent energy flux (2). Low 
mitochondrial content is therefore consistent with a 
role in regulating signalling responses to environmental 
cues rather than energy production per se (8), however 
mitochondrial respiration is still necessary for 
angiogenesis as inhibition of respiratory chain complex 
III impairs proliferation (with no change in migration) 
of EC in vitro following a decrease in the NAD+/NADH 
ratio (9). Communication among organelles is, of course, 
dependent on location. Regulation of fusion and fission 
will affect mitochondrial distribution and hence potential 
function: in coronary arterioles they are anchored to the 
cytoskeleton which facilitates flow-mediated dilatation 
(10), while hypoxia invokes mitochondrial redistribution 
around nuclei of pulmonary artery EC (11). Although 
the importance of EC dysfunction is well known (12, 
13), there are many potential roles for mitochondria in 
vascular responses to various stressors (Table 1); we choose 
to highlight a few of many in this short review.
Interventions impacting vascular 
mitochondrial signalling
Various approaches have been established to modulate 
vascular-located mitochondria and their signalling/
metabolism (Table 1). However, most interventions 
seem to largely impact vascular mitochondrial signalling 
properties (unsurprisingly given the low content found 
within EC), which are especially sensitive to exercise, 
hypoxia, nutrition, and pharmacological treatments. 
In addition, other conditions have provided key insight 
into how normal mitochondrial function in vascular 
cells becomes disrupted with ageing and/or disease. What 
remains clear is that modulating mitochondrial properties 
Table 1 Summary of the vascular mitochondrial responses/signals linked to a subsequent angiogenic response and the putative 
stressors involved.
Mitochondrial response/signal Impact on angiogenesis Stressor(s) Reference(s)
Biogenesis + Hypoxia; caloric restriction; drugs (4, 16, 17)
Shift in fuel oxidation - Hyperglycaemia; diabetes (19, 22, 23)
Elevated ROS - Ageing; disease; hypoxia (14, 15, 22, 23, 25) 
Antioxidant capacity + Exercise; drugs (4, 11, 12, 13, 28, 29, 30)
Fission/fusion imbalance - Hyperglycaemia; IR injury (15)
Oxidative capacity ? Exercise; ageing; nitric oxide (11, 12, 14, 15)
Intrinsic respiratory function ? Exercise (11)
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can have important consequences for subsequent vascular 
remodelling, which offers a novel therapeutic target 
worthy of future focus. While the following may also 
be relevant to perivascular cells, for example, pericyte 
production of ROS induced by oxidised LDL (14), in the 
interest of space we concentrate on EC responses per se.
Exercise 
Exercise training is well known to benefit vascular 
function (15), with mitochondrial signalling implicated 
to play a key role. Both acute and chronic exercise regimes 
have important effects on both mitochondrial signalling 
and morphology/function. Endurance training stimulates 
improvements in mitochondrial oxidative capacity, as 
measured from in situ isolated mouse arteries, inducing 
higher levels of mitochondrial respiration (complex I and 
II) alongside improving coupling efficiency, but without 
parallel increases in mitochondrial content (as often seen 
in other tissues such as skeletal muscle) (16). As such, 
these data suggest intrinsic mitochondrial function may 
be more sensitive and of greater importance for driving 
exercise-related vascular benefits than mitochondrial 
content per se. Moreover, as complexes I and III are 
considered to be the main sources of mitochondrial ROS, 
it is interesting to note that functional improvements 
were specific to these sites (16). Many of the exercise-
related benefits seem to be consequent to activation of 
the key nuclear transcriptional co-activator PGC-1α, 
which is upregulated in vascular tissue following exercise 
training alongside higher eNOS levels and lower ROS 
production (16, 17). In vitro experiments have confirmed 
that EC-specific overexpression of PGC-1α activates the 
anti-oxidative enzyme transcription network to lower 
mitochondrial-derived ROS (18). Thus, exercise training 
seems to improve vascular function by modulating eNOS 
activity in a redox-sensitive manner, which may be driven 
by improvements in intrinsic EC mitochondrial function. 
Further studies are warranted to clarify this issue.
Ageing and disease 
Ageing and disease are both closely related to impaired 
vascular function. Assessment of feed arteries has shown 
ageing lowers mitochondrial respiration and this is 
paralleled by higher mitochondrial ROS generation (19). 
While data clearly show mitochondrial ROS production 
is intimately involved in vascular dysfunction, the 
underlying signalling cascades and how mitochondrial 
function impacts angiogenesis remain poorly understood.
Ischaemia/inflammation 
One clue may come from the response to tissue 
ischaemia, where a low PO2 impairs mitochondrial 
respiration, favouring ROS production and hence EC 
dysfunction. In atherosclerosis, decreased vascular tone 
regulation is linked to disturbed NO production, which 
in turn promotes oxidative stress, platelet aggregation 
and leukocyte adhesion (20). EC mitochondria respond 
to hypoxia-induced VEGF with increased biogenesis via 
AKT-dependent signalling, resulting in increased vascular 
branching (21), a process reversed by inhibiting biogenesis 
via the silencing of SIRTUIN1 (22). As SIRTUIN3 is critical 
for EC glycolysis and angiogenesis, deficiency predisposes 
to coronary endothelial dysfunction and increases the 
risk for developing heart failure (23). Fatty acid oxidation 
(FAO) is essential for EC proliferation during angiogenesis, 
so promoting mitochondrial FAO (24) or supressing NO 
inhibition may be useful goals for further work. In addition, 
FAO is important for maintaining redox homeostasis, 
by regeneration of NADPH through tricarboxylic acid 
cycle activity, and hence, may offer protection against 
EC dysfunction caused by oxidative stress via NOTCH1 
regulation (25). Interestingly, supplementation of acetate 
to increase levels of acetyl-coenzyme A may lead to 
vasculoprotection against oxidative stress-induced EC 
dysfunction. Indeed, this concept may also apply to the 
related process of lymphangiogenesis where β-oxidation 
is essential for the development of lymphatic EC, and 
acetate supplementation may potentiate injury-induced 
lymphangiogenesis (26). In addition, mitochondrial-
targetted peptides may reduce mitochondrial dysfunction 
and aberrant inflammatory response through activation 
of nucleotide-binding oligomerisation domain (NOD)-
like family receptors (27).
Diabetes 
Elevated glucose levels in diabetes lead to an increased 
expression of insulin receptors and downstream elements 
of the insulin-signalling pathway (28). A common theme 
for EC dysfunction begins to emerge where uncoupling 
of eNOS and increased EC mitochondrial ROS production 
with hyperglycaemia impair glycolysis by activation 
of PARP. This may then drive a metabolic realignment 
in EC towards oxidative phosphorylation (29, 30), but 
in parallel induce EC mitochondriopathy (31). EC ROS 
production, by activating NADPH-dependent oxidase, 
leads to EC and vascular smooth muscle dysfunction 
and oxidative damage. Mitochondrial DNA is sensitive to 
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modification by ROS, which is observed in cardiovascular 
disease, smoking, hypercholesterolemia, and obesity (32), 
suggesting an important therapeutic target.
Tumours 
Tumours require an extensive vascular supply to support 
high metabolic rates. Thus, starving tumour cells by 
disrupting their vascular supply provides a rationale for 
many current therapies. Anti-angiogenesis drugs, for 
e.g. monoclonal antibodies such as Avastin or receptor 
tyrosine kinase inhibitors like Sunitinib, are used to 
target colorectal, non-small-cell lung, ovarian, peritoneal, 
renal cell and cervical cancers; unfortunately, in most 
cases treatment provides only a modest improvement in 
overall patient survival (33). However, reprogramming 
EC metabolism in the tumour environment may also 
modulate the excessive angiogenesis (34), as the tumour 
environment is deprived of nutrients and oxygen, 
and both tumour and stromal cells must produce large 
amounts of energy and macromolecular precursors 
(nucleotides, lipids, amino acids) for rapid growth. EC 
metabolism and its regulation are therefore centrally 
involved in vessel growth, survival and function, and 
may offer novel and alternative targets to interfere with 
or stimulate angiogenesis. While the hyperglycolytic 
EC phenotype has been described (35), similar studies 
identifying mitochondrial targets are lacking.
Drugs 
Various pharmacological studies have been employed 
to shed important light on the mechanistic role of 
mitochondrial signalling in coordinating vascular 
remodelling. This has included the use of small-molecules 
to activate key upstream mitochondrial molecular 
regulators (transcription factors or co-factors) including 
AMPK, PGC-1α, and SIRTUIN (4), although much work 
is still required to confirm in vivo efficacy. Another 
major focus has been to use mitochondrial-specific 
antioxidants (e.g. MitoQ, mito-tempol). Recent work in 
humans extended experiments performed in rodents (36), 
showing that chronic oral administration of MitoQ for 
6 weeks improved the endothelial functional index of 
brachial-artery flow-mediated dilatation in healthy older 
humans (37). While more extensive work is required 
Figure 1
Some aspects of mitochondrial biology, illustrating the key findings and concepts relevant to vascular biology, with particular emphasis on endothelial 
cells and angiogenesis.
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to show whether mitochondrial-specific antioxidant 
therapies directly impact angiogenesis in humans, initial 
evidence is promising. It does appear, however, that 
mitochondrial rather than cytosolic-specific antioxidants 
(i.e. catalase) provide greater benefits to vascular function 
(38), supporting the contention that focus in this area 
should be directed towards mitochondrial-targetted redox 
signalling. Despite much evidence now indicating ROS 
as negative regulators of vascular function, antioxidant 
interventions should be applied with caution given that 
a minimum level of ROS are required for maintaining 
normal vascular health. Hence, while acute increases in 
mitochondrial ROS (e.g. induced via exercise) are key for 
maintaining normal vascular health, a chronic increase is 
detrimental as observed during disease.
Conclusions and future directions
ECs play a key role in supporting angiogenesis and 
maintaining health; yet, they are predominately fuelled 
by glycolysis rather than oxidative phosphorylation in 
which the mitochondria occupy a small cellular volume. 
However, EC mitochondria are dynamic and adapt to 
their local environment, such that they provide more 
energy during proliferation, in response to hypoxia, and 
when challenged by hyperglycaemia. In recent years it 
has become clear that one major role for mitochondria in 
EC is to modulate cellular signalling cascades in response 
to various stromal cues such as seen with hypoxia, 
exercise, ischaemia, ageing, and disease (Fig. 1). Thus, 
contemporary evidence now supports EC mitochondria 
as major signalling hubs responsible for maintaining 
vascular homeostasis. One key role seems to be their 
ability to modulate redox signalling and future avenues 
should target this pathway as a means of angiogenic 
therapy. While many questions remain, such as what 
differences exist between macro- and microvascular EC 
phenotype, further research on understanding the role 
of mitochondria in EC beyond energy metabolism will 
likely yield more effective treatments for modulating 
angiogenesis in a tissue-specific manner.
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